Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Metastatic Malignant Neoplasm
Washington University School of Medicine
P1/2
CC
(43)
Memory-Like Natural Killer Cells
Acute Myeloid Leukemia
Washington University School of Medicine
P1/2
CC
(43)
Rabbit Anti-Thymocyte Globulin
Acute Myeloid Leukemia
Washington University School of Medicine
P1/2
CC
(43)
Tcr Alpha Beta / Cd19+ Depleted Haploidentical Hematopoietic Progenitor Cell Graft
Acute Myeloid Leukemia
Washington University School of Medicine
P1/2
CC
(43)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Malignant Pancreatic Neoplasm
Washington University School of Medicine
P1
CC
(42)
Allopurinol
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
Allopurinol
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
Dsp-0390
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
Mammaglobin-A Dna Vaccine
Breast Carcinoma
Washington University School of Medicine
P1
CC
(41)
MERCAPTOPURINE ANHYDROUS
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
METHOTREXATE
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
Monomethyl Fumarate
Small Cell Lung Carcinoma
Washington University School of Medicine
P1
CC
(41)
Tulmimetostat
Mycosis Fungoides
Washington University School of Medicine
P1
CC
(41)
Tulmimetostat
Sezary Syndrome
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Anaplastic Large Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Angioimmunoblastic T-Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Extranodal Nasal NK/T Cell Lymphoma
Washington University School of Medicine
P1
CC
(41)
Wu-Cart-007
Sezary Syndrome
Washington University School of Medicine
P1
CC
(41)
Zunsemetinib
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine
P1
CC
(41)
Cabiralizumab
Triple-Negative Breast Carcinoma
Washington University School of Medicine
P1/2
CC
(41)
Ctx-009
Glioblastoma
Washington University School of Medicine
P1/2
CC
(41)
Ctx-471
Glioblastoma
Washington University School of Medicine
P1/2
CC
(41)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Gastric Cancer
Washington University School of Medicine
P1/2
CC
(41)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Liver Cancer
Washington University School of Medicine
P1/2
CC
(41)
Epacadostat
Rectal Carcinoma
Washington University School of Medicine
P1/2
CC
(41)
Showing 201 to 225 of 278 assets
Previous
Page 9 of 12
Next